In this episode of The Upgrade podcast, we discuss Sotera and Parexel; how they have fared in the pandemic and what would be required for an upgrade. We also discuss where they rank in the Top 250 and how their respective debt pricing may be viewed by CLO managers. Guests are analysts from S&P’s U.S. corporate ratings healthcare team and CLO team.
Our aim is to provide market participants with further advanced analytical insight into Corporate Credits, CLOs and Leveraged Finance deals, with S&P Global Ratings regular podcast, based on key features we’re seeing in corporate credits and sectors that CLOs are exposed to. For more Leveraged Finance and CLOs Insights visit Leveraged Finance & CLOs Essentials